{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:54:15Z","timestamp":1791179655366,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Sarcopenia, prevalent in interstitial lung disease (ILD), increases the risk of poor outcomes. This study aimed to define the clinical characteristics of ILD patients with sarcopenia (ILD-S) and quantify sarcopenia's impact on mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We systematically searched PubMed, Embase, Cochrane Library, Web of Science, and Scopus for English studies up to 1 September 2026 reporting clinical variables (mean\u2009\u00b1\u2009SD) in ILD vs. ILD-S groups and adjusted hazard ratios with 95% confidence intervals (CI) for mortality risk. Subgroup analyses were stratified by sarcopenia diagnostic criteria, ILD subtype, and survival time. Heterogeneity was assessed using Cochran's Q and I\n                      <jats:sup>2<\/jats:sup>\n                      statistics. Sensitivity analyses (leave-one-out) and publication bias assessments (Egger's test, trim-and-fill method) were performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fourteen studies comprising 1,546 participants (628 with ILD-S) were included. Compared with ILD patients without sarcopenia, those with ILD-S were significantly older (WMD\u2009=\u20093.03, 95% CI: 2.12\u20133.93), had higher Gender-Age-Physiology (GAP) scores (WMD\u2009=\u20090.43, 95% CI: 0.15 to 0.71), and a higher FEV\u2081\/FVC ratio (WMD\u2009=\u20091.97, 95% CI: 0.21 to 3.73,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03). Conversely, the ILD-S group showed lower values for FEV\u2081% predicted (WMD\u2009=\u2009\u22126.95, 95% CI: \u22129.80 to \u22124.09), FVC% predicted (WMD\u2009=\u2009\u22129.46, 95% CI: \u221212.04 to \u22126.88), DLCO% predicted (WMD\u2009=\u2009\u22125.87, 95% CI: \u221211.68 to \u22120.06), body mass index (WMD\u2009=\u2009\u22121.35, 95% CI: \u22121.89 to \u22120.82), handgrip strength (WMD\u2009=\u2009\u221212.80, 95% CI: \u221217.02 to \u22128.58), 6-minute walk distance (WMD\u2009=\u2009\u221231.01, 95% CI: \u221260.05 to \u22121.97), and appendicular skeletal muscle index (WMD\u2009=\u2009\u22121.45, 95% CI: \u22122.15 to \u22120.76). No significant difference was observed in smoking history. Sarcopenia was strongly associated with increased mortality risk (HR\u2009=\u20092.02, 95% CI: 1.67 to 2.45), and this association remained stable across different follow-up periods. Sensitivity and publication bias analyses confirmed the robustness of the findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with ILD-S exhibit a distinctive profile characterized by older age, higher GAP scores, poorer pulmonary function, lower BMI, reduced muscle strength and mass, and significantly elevated mortality. Systematic recognition of these clinical features may facilitate early identification of ILD-S and inform the development of targeted interventions to improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/inplasy.com\/<\/jats:ext-link>\n                      , INPLASY202570030.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1955396","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:49Z","timestamp":1791178369000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and mortality risk of sarcopenia in interstitial lung disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Lijuan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nursing, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Nursing, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University","place":["Chengdu, China"]},{"name":"State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"751181","DOI":"10.3389\/fmed.2021.751181","article-title":"Variability in global prevalence of interstitial lung disease","volume":"8","author":"Kaul","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"00058\u20132022","DOI":"10.1183\/23120541.00058-2022","article-title":"Interstitial lung disease incidence and mortality in the UK and the European union: an observational study, 2001\u20132017","volume":"8","author":"Salciccioli","year":"2022","journal-title":"ERJ Open Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"180061","DOI":"10.1183\/16000617.0061-2018","article-title":"Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unit","volume":"27","author":"Huapaya","year":"2018","journal-title":"Eur Respir Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17842","DOI":"10.1038\/s41598-024-68754-4","article-title":"Malnutrition is associated with mortality in Sjogren\u2019s syndrome-associated interstitial lung disease","volume":"14","author":"Chung","year":"2024","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2311845","DOI":"10.1080\/07853890.2024.2311845","article-title":"Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"56","author":"He","year":"2024","journal-title":"Ann Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/resp.12571","article-title":"Skeletal muscle atrophy in advanced interstitial lung disease","volume":"20","author":"Mendes","year":"2015","journal-title":"Respirology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/resp.14892","article-title":"Dynapenia and sarcopenia as risk factors for mortality in interstitial lung disease","volume":"30","author":"Ibarra-Fern\u00e1ndez","year":"2025","journal-title":"Respirology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12890-022-01840-3","article-title":"A comparative study of the sarcopenia screening in older patients with interstitial lung disease","volume":"22","author":"Hanada","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.21037\/jtd-24-1631","article-title":"Association of sarcopenia with basic activities of daily living and dyspnea-related limitations in patients with interstitial lung disease","volume":"17","author":"Taketa","year":"2025","journal-title":"J Thorac Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"240126","DOI":"10.1183\/16000617.0126-2024","article-title":"Sarcopenia in interstitial lung disease","volume":"33","author":"Sheehy","year":"2024","journal-title":"Eur Respir Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12931-024-02705-5","article-title":"Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis","volume":"25","author":"Sridhar","year":"2024","journal-title":"Respir Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","article-title":"Imaging of sarcopenia: old evidence and new insights","volume":"30","author":"Albano","year":"2020","journal-title":"Eur Radiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"B19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14799731221117298","DOI":"10.1177\/14799731221117298","article-title":"Frequency and impact on clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Fujita","year":"2022","journal-title":"Chron Respir Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100965","DOI":"10.1016\/j.resmer.2022.100965","article-title":"Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis","volume":"82","author":"Fujikawa","year":"2022","journal-title":"Respir Med Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/1759-7714.14294","article-title":"Impact of sarcopenia on chemotherapy-triggered exacerbation of interstitial lung disease in patients with non-small cell lung cancer","volume":"13","author":"Kikuchi","year":"2022","journal-title":"Thorac Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.crad.2023.08.011","article-title":"Reduced CT-derived erector spinae muscle area: a poor prognostic factor for short- and long-term outcomes in idiopathic pulmonary fibrosis patients","volume":"78","author":"\u00c7inkoo\u011flu","year":"2023","journal-title":"Clin Radiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/arm93030011","article-title":"Malnutrition, sarcopenia, and malnutrition sarcopenia syndrome in idiopathic pulmonary fibrosis","volume":"93","author":"Cabrera-C\u00e9sar","year":"2025","journal-title":"Adv Respir Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12890-025-03942-0","article-title":"Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias","volume":"25","author":"Hagiwara","year":"2025","journal-title":"BMC Pulm Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/arm94020024","article-title":"Prognostic impact of serum transthyretin and sarcopenia on 3-year mortality and respiratory-related hospitalizations in idiopathic pulmonary fibrosis: a prospective cohort study","volume":"94","author":"Okada","year":"2026","journal-title":"Adv Respir Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1440402","DOI":"10.3389\/fnut.2024.1440402","article-title":"Rectus femoris cross sectional area and timed up and go test potential useful of as a predictor of sarcopenia and mortality in idiopathic pulmonary fibrosis","volume":"11","author":"Fern\u00e1ndez-Jim\u00e9nez","year":"2024","journal-title":"Front Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12931-022-02159-7","article-title":"Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach","volume":"23","author":"Faverio","year":"2022","journal-title":"Respir Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12931-019-1001-6","article-title":"Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients","volume":"20","author":"Moon","year":"2019","journal-title":"Respir Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.resinv.2024.07.019","article-title":"Usefulness of serum transthyretin for prediction of the 1-year outcome in idiopathic pulmonary fibrosis: an evaluation of sarcopenic and nutritional indicators","volume":"62","author":"Fujita","year":"2024","journal-title":"Respir Investig"},{"key":"B33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1017\/S0954422421000135","article-title":"Understanding the role of smoking and chronic excess alcohol consumption on reduced caloric intake and the development of sarcopenia","volume":"35","author":"Prokopidis","year":"2022","journal-title":"Nutr Res Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000512315","article-title":"S2k guideline for diagnosis of idiopathic pulmonary fibrosis","volume":"100","author":"Behr","year":"2021","journal-title":"Respiration"},{"key":"B35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1378\/chest.14-0453","article-title":"Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis","volume":"147","author":"Kim","year":"2015","journal-title":"Chest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12931-016-0454-0","article-title":"Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study","volume":"17","author":"Lee","year":"2016","journal-title":"Respir Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"106539","DOI":"10.1016\/j.rmed.2021.106539","article-title":"Pectoralis muscle area and its association with indices of disease severity in interstitial lung disease","volume":"186","author":"Molgat-Seon","year":"2021","journal-title":"Respir Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE study group","volume":"14","author":"Bauer","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"B39","doi-asserted-by":"publisher","first-page":"109943","DOI":"10.1016\/j.ejrad.2021.109943","article-title":"Methodology, clinical applications, and future directions of body composition analysis using computed tomography (CT) images: a review","volume":"145","author":"Tolonen","year":"2021","journal-title":"Eur J Radiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"11369","DOI":"10.1038\/s41598-018-29825-5","article-title":"Skeletal muscle cutoff values for sarcopenia diagnosis using t10 to l5 measurements in a healthy US population","volume":"8","author":"Derstine","year":"2018","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/jcsm.13115","article-title":"Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand","volume":"14","author":"Zanker","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B42","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s12603-020-1361-0","article-title":"Prevalence and risk factors governing the loss of muscle function in elderly sarcopenia patients: a longitudinal study in China with 4 years of follow-up","volume":"24","author":"Zhang","year":"2020","journal-title":"J Nutr Health Aging"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2300442","DOI":"10.1183\/13993003.00442-2023","article-title":"European respiratory society statement on frailty in adults with chronic lung disease","volume":"62","author":"Osadnik","year":"2023","journal-title":"Eur Respir J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"14799731231196582","DOI":"10.1177\/14799731231196582","article-title":"Prevalence and assessment of frailty in interstitial lung disease - a systematic review and meta-analysis","volume":"20","author":"Weber","year":"2023","journal-title":"Chron Respir Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1955396\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:50Z","timestamp":1791178370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1955396\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":44,"alternative-id":["10.3389\/fmed.2026.1955396"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1955396","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1955396"}}